Skip to content

Assessment of oral glucose solution & maternal abdominal palpation effect on fetal non stress test.

Assessment of oral glucose solution & maternal abdominal palpation effect on fetal non stress test.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2012082110635N1
Enrollment
150
Registered
2012-12-31
Start date
2018-12-22
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non Stress Test. Labour and delivery complicated by fetal stress, unspecified

Interventions

Intervention 1: All pregnant women will assess in the same conditions, such as same quiet room and semi recumbent position. Women with non reactive NST randomly assign for oral ingestion of 50g of glu

Sponsors

Vice Chancellor for Research and Thecnology Research, Hamadan university of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
No minimum to 35 Years

Inclusion criteria

Inclusion criteria: Age 18 to 35 years old Gestational age 34 to 41 weeks Single pregnancy Infertility failure Having regular pregnancy care The absence of any illness in pregnancy (diabetes, blood pressure and ...) Having a normal glucose tolerance test at 28-24 weeks of gestation No smoking No Hydramnios and Intrauterine death no recognize congenital anomalies of the fetus to Do not use narcotics, opiates or other drugs by the mother

Exclusion criteria

Exclusion criteria: abnormal fetal heart rate

Design outcomes

Primary

MeasureTime frame
Fetal movement. Timepoint: 20 minutes after ingestion of 50g of glucose in 250ml of water or Immediately after maternal abdominal palpation. Method of measurement: fetal non stress test.;Fetal heart rate. Timepoint: 20 minutes after ingestion of 50g of glucose in 250ml of water or Immediately after maternal abdominal palpation. Method of measurement: fetal non stress test.

Secondary

MeasureTime frame
Increase fetal heart rate. Timepoint: At the time of testing. Method of measurement: Fetal heart ratemonitoring.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAghababaei Soodabeh

Nursing & Midwifery Faculty; Hamadan Medical university of Iran.

aghababaii@yahoo.com+98 81 3838 0535

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026